Washington, D.C.—The Supreme Court denied Amarin’s final petition for appeal, protecting fish oil supplements, according to a press release from the Council for Responsible Nutrition (CRN). In August 2017, the release notes, Amarin Pharma filed a complaint with the ITC against 18 manufacturers of EPA omega-3 fish oil supplements and...
The U.S. Court of Appeals (USCA) for the Federal Circuit has upheld the decision of the International Trade Commission (ITC) to dismiss a complaint from Amarin Pharma, Inc., that certain companies were falsely labeling and advertising omega-3 products as “dietary supplements,” when they were actually “new drugs” as per the...
As expected, Amarin Corp. is appealing to the U.S. Federal Circuit Court the International Trade Commission’s decision to decline its request to block the import of ethyl ester and triglyceride concentrates for dietary supplements. ITC had rejected Amarin’s initial request because it said interpretation of the Food Drug...
